240 related articles for article (PubMed ID: 14579727)
1. Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.
Yoshino I; Yamaguchi M; Yohena T; Kameyama T; Kometani T; Osoegawa A; Maehara Y
Fukuoka Igaku Zasshi; 2003 Aug; 94(8):250-8. PubMed ID: 14579727
[TBL] [Abstract][Full Text] [Related]
2. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
Casali C; Stefani A; Natali P; Rossi G; Morandi U
Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
[TBL] [Abstract][Full Text] [Related]
4. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
5. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
6. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
7. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
8. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
10. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
11. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
13. Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
Watanabe A; Mishina T; Ohori S; Koyanagi T; Nakashima S; Mawatari T; Kurimoto Y; Higami T
Eur J Cardiothorac Surg; 2008 May; 33(5):812-8. PubMed ID: 18342533
[TBL] [Abstract][Full Text] [Related]
14. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
Misthos P; Sepsas E; Athanassiadi K; Kakaris S; Skottis I
Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
[TBL] [Abstract][Full Text] [Related]
15. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
16. Skip mediastinal nodal metastases in non-small cell lung cancer.
Tanaka F; Takenaka K; Oyanagi H; Fujinaga T; Otake Y; Yanagihara K; Ito H; Wada H
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1114-20. PubMed ID: 15145018
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
18. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
20. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]